Inhibition of the Canonical IKK/NFκB Pathway Sensitizes Human Cancer Cells to Doxorubicin

JOURNAL ARTICLE published 15 September 2007 in Cell Cycle

Authors: Maria A. Tapia | Irene González-Navarrete | Alba Dalmases | Marta Bosch | Vanesa Rodriguez-Fanjul | Mark Rolfe | Jeffrey S. Ross | Jovita Mezquita | Cristobal Mezquita | Oriol Bachs | Pere Gascón | Federico Rojo | Rosario Perona | Ana Rovira | Joan Albanell